HIV‐1 Coreceptor Use in Triple‐Class Treatment–Experienced Patients: Baseline Prevalence, Correlates, and Relationship to Enfuvirtide Response

Abstract
ObjectiveWe wished to assess, in heavily treatment-experienced patients, the prevalence of and baseline characteristics associated with HIV-1 corecep